BFRI · Biofrontera Inc.
$1.44
+0.09 (+6.67%)
At close · Aug 18
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$19.31M
Shares
14.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Prof. Hermann Luebbert Ph.D | Chairman and Chief Executive Officer | $873,232 |
| Fred Leffler | Chief Financial Officer | $554,209 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Prof. Hermann Luebbert Ph.D | Chairman and Chief Executive Officer | $1,302,917 |
| Fred Leffler | Chief Financial Officer | $832,626 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Prof. Hermann Lübbert Ph.D | Executive Chairman | $839,722 |
| Erica Monaco | CPA, Chief Executive Officer | $812,972 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Erica Monaco | CPA, Chief Executive Officer | $311,456 |
| Prof. Hermann Lübbert Ph.D | Executive Chairman | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| George Jones | Chief Commercial Officer | Appointed | 2025-08-11 |
| Prof. Hermann Luebbert, Ph.D. | Class III director | Appointed | 2024-06-14 |
| John J. Borer III | Class III director | Appointed | 2024-06-14 |
| Heikki Lanckriet | Class I Director | Appointed | 2023-07-12 |
| Erica Monaco | Chief Executive Officer | Resigned | 2023-05-26 |
| Hermann Luebbert | Chief Executive Officer | Appointed | 2023-05-26 |
| Erica Monaco | Chief Executive Officer | Resigned | 2023-05-12 |
| Loretta Wedge | Class I Director | Appointed | 2022-12-16 |
| Fred Leffler | Chief Financial Officer | Appointed | 2022-10-24 |
| Kevin D. Weber | Class II Director | Appointed | 2022-03-08 |
| Beth J. Hoffman | board of directors | Appointed | 2021-11-03 |
| Loretta M. Wedge | board of directors | Appointed | 2021-11-03 |
| John J. Borer | board of directors | Appointed | 2021-11-03 |
| Erica Monaco | board of directors | Resigned | 2021-11-03 |
Key facts
CIK
1858685
CUSIP
09077D209
13F (30d)
24 filings
23 filers
Visit website
Investor relations